GSK logo on the side of a building
Media playback is unsupported on your device

GlaxoSmithKline finance boss banned from leaving China

Chinese authorities looking into alleged bribery by GlaxoSmithKline have banned the UK drugmaker's British head of finance from leaving China.

The travel ban was imposed on Steve Nechelput at the end of June, said a company spokesperson.

On Monday, police in China said GSK had transferred 3bn yuan ($489m; £321m) to travel agencies and consultancies to facilitate bribes to doctors.

GSK has said it is deeply "concerned and disappointed" by the allegations.

Martin Patience reports from Beijing.

Go to next video: GSK under fire in China 'bribes' row